Jerome  Cambre net worth and biography

Jerome Cambre Biography and Net Worth

Jerome Cambre is the VP of Viemed Healthcare. They are 55 years old.

What is Jerome Cambre's net worth?

The estimated net worth of Jerome Cambre is at least $838.54 thousand as of August 13th, 2025. Cambre owns 84,191 shares of Viemed Healthcare stock worth more than $838,542 as of April 30th. This net worth evaluation does not reflect any other assets that Cambre may own. Learn More about Jerome Cambre's net worth.

How do I contact Jerome Cambre?

The corporate mailing address for Cambre and other Viemed Healthcare executives is 625 East Kaliste Saloom Road, Lafayette LA, 70508. Viemed Healthcare can also be reached via phone at (337) 504-3802 and via email at [email protected]. Learn More on Jerome Cambre's contact information.

Has Jerome Cambre been buying or selling shares of Viemed Healthcare?

Jerome Cambre has not been actively trading shares of Viemed Healthcare during the last quarter. Most recently, Jerome Cambre sold 4,880 shares of the business's stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $7.32, for a transaction totalling $35,721.60. Following the completion of the sale, the vice president now directly owns 84,191 shares of the company's stock, valued at $616,278.12. Learn More on Jerome Cambre's trading history.

Who are Viemed Healthcare's active insiders?

Viemed Healthcare's insider roster includes Jerome Cambre (VP), Randy Dobbs (Director), Sabrina Heltz (Director), Nitin Kaushal (Director), and Michael Moore (President). Learn More on Viemed Healthcare's active insiders.

Are insiders buying or selling shares of Viemed Healthcare?

In the last twelve months, insiders at the sold shares 7 times. They sold a total of 234,724 shares worth more than $1,941,862.42. The most recent insider tranaction occured on March, 20th when President Michael Moore sold 65,000 shares worth more than $570,050.00. Insiders at Viemed Healthcare own 20.0% of the company. Learn More about insider trades at Viemed Healthcare.

Information on this page was last updated on 3/20/2026.

Jerome Cambre Insider Trading History at Viemed Healthcare

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/13/2025Sell4,880$7.32$35,721.6084,191View SEC Filing Icon  
See Full Table

Jerome Cambre Buying and Selling Activity at Viemed Healthcare

This chart shows Jerome Cambre's buying and selling at Viemed Healthcare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Viemed Healthcare Company Overview

Viemed Healthcare logo
Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Read More

Today's Range

Now: $9.96
Low: $9.82
High: $10.04

50 Day Range

MA: $9.27
Low: $8.24
High: $10.05

2 Week Range

Now: $9.96
Low: $5.93
High: $10.10

Volume

186,303 shs

Average Volume

246,917 shs

Market Capitalization

$383.30 million

P/E Ratio

26.92

Dividend Yield

N/A

Beta

1.16